Published in Am J Cardiol on August 23, 2011
Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease. Circulation (2014) 2.03
The molecular targets of approved treatments for pulmonary arterial hypertension. Thorax (2015) 0.90
Pulmonary arterial hypertension in adults: novel drugs and catheter ablation techniques show promise? Systematic review on pharmacotherapy and interventional strategies. Biomed Res Int (2014) 0.82
Continuous flow left ventricular assist device implant significantly improves pulmonary hypertension, right ventricular contractility, and tricuspid valve competence. J Card Surg (2013) 0.80
Long-Term Survival of Patients with Pulmonary Arterial Hypertension at a Single Center in Taiwan. Acta Cardiol Sin (2017) 0.77
Network meta-analysis combining individual patient and aggregate data from a mixture of study designs with an application to pulmonary arterial hypertension. BMC Med Res Methodol (2015) 0.77
Combination of erythropoietin and sildenafil can effectively attenuate hypoxia-induced pulmonary hypertension in mice. Pulm Circ (2013) 0.77
Epidemiology and clinical management of pulmonary hypertension in children. Korean Circ J (2012) 0.77
The Action of Smooth Muscle Cell Potassium Channels in the Pathology of Pulmonary Arterial Hypertension. Pediatr Cardiol (2016) 0.76
Does treatment response to ambrisentan vary by pulmonary arterial hypertension severity? Implications for clinicians and for the design of future clinical trials. Int J Clin Pract (2014) 0.75
Combination therapy in pulmonary arterial hypertension: recent accomplishments and future challenges. Pulm Circ (2017) 0.75
Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol (2009) 12.05
Clinical classification of pulmonary hypertension. J Am Coll Cardiol (2004) 5.87
Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med (2013) 5.60
Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation. Am J Cardiol (2012) 2.76
Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med (2003) 2.64
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol (2006) 2.42
Off-pump vs. on-pump coronary artery bypass surgery: an updated meta-analysis and meta-regression of randomized trials. Eur Heart J (2011) 1.96
Meta-analysis of ten trials on the effectiveness of the radial versus the femoral approach in primary percutaneous coronary intervention. Am J Cardiol (2011) 1.91
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease. Ann Rheum Dis (2007) 1.72
Sex-related differences in access to care among patients with premature acute coronary syndrome. CMAJ (2014) 1.67
High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. Eur Respir J (2012) 1.62
Safety of laparoscopic vs open bariatric surgery: a systematic review and meta-analysis. Arch Surg (2011) 1.58
Symptomatic Brugada unmasked by fever. Isr Med Assoc J (2008) 1.49
Pulmonary arterial hypertension: pathophysiology and anesthetic approach. Anesthesiology (2003) 1.42
Hemodynamic stability after transitioning between endothelin receptor antagonists in patients with pulmonary arterial hypertension. Can J Cardiol (2012) 1.42
Acute vasodilator responsiveness and microvascular recruitment in idiopathic pulmonary arterial hypertension. Ann Intern Med (2015) 1.42
Isolated aerobic exercise and weight loss: a systematic review and meta-analysis of randomized controlled trials. Am J Med (2011) 1.16
Acute coronary syndrome associated with myocardial bridging due to ergotamine treatment for migraine. Int J Cardiol (2006) 1.14
Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum (2013) 1.04
Pulmonary capillary hemangiomatosis: the puzzle takes shape. Chest (2014) 0.99
Endothelin in coronary artery disease and myocardial infarction. Cardiol Rev (2013) 0.96
Bone morphogenic protein-9 stimulates endothelin-1 release from human pulmonary microvascular endothelial cells: a potential mechanism for elevated ET-1 levels in pulmonary arterial hypertension. Microvasc Res (2010) 0.95
Temporal trends and drug exposures in pulmonary hypertension: an American experience. Am Heart J (2006) 0.94
Incidence and significance of pericardial effusion in patients with pulmonary arterial hypertension. Can J Cardiol (2012) 0.93
Incremental value of the preoperative echocardiogram to predict mortality and major morbidity in coronary artery bypass surgery. Circulation (2012) 0.89
Pulmonary arterial hypertension in the elderly-clinical characteristics and long-term survival. Lung (2012) 0.89
Incidence, predictors and outcome of upper gastrointestinal bleeding in patients with acute coronary syndromes. Int J Cardiol (2011) 0.87
Eisenmenger syndrome and atrial septal defect: nature or nurture? Can J Cardiol (2006) 0.86
The endothelin system in pulmonary hypertension. Can J Physiol Pharmacol (2003) 0.85
ALK2 and BMPR2 knockdown and endothelin-1 production by pulmonary microvascular endothelial cells. Microvasc Res (2012) 0.84
Meta-analysis of randomized controlled trials of intracoronary versus intravenous administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol (2011) 0.83
Effects of bone morphogenic proteins and transforming growth factor-beta on In-vitro production of endothelin-1 by human pulmonary microvascular endothelial cells. Vascul Pharmacol (2008) 0.83
Altitude-related hypoxia: risk assessment and management for passengers on commerical aircraft. Aviat Space Environ Med (2003) 0.82
Depressive symptoms in relation to physical functioning in pulmonary hypertension. J Psychosom Res (2008) 0.82
[Popliteal cyst rupture due to unusual physical stress]. Harefuah (2007) 0.82
Prevalence and impact of coronary artery disease in patients with pulmonary arterial hypertension. Am J Cardiol (2011) 0.81
The effect of bariatric surgery on echocardiographic indices: a review of the literature. Eur J Clin Invest (2013) 0.81
Lymphedema: a comprehensive review. Ann Plast Surg (2008) 0.81
Meta-analysis of randomized controlled trials on effect of cilostazol on restenosis rates and outcomes after percutaneous coronary intervention. Am J Cardiol (2012) 0.81
Vascular endothelium summary statement V: Pulmonary hypertension and acute lung injury: public health implications. Vascul Pharmacol (2006) 0.80
Breast cancer-related lymphedema: a randomized controlled pilot and feasibility study. Am J Phys Med Rehabil (2014) 0.79
Matrix metalloproteinases in the urine of patients with pulmonary arterial hypertension. Chest (2005) 0.78
Aqua lymphatic therapy in managing lower extremity lymphedema. J Support Oncol (2007) 0.78
[Definitions and diagnosis of pulmonary hypertension]. Turk Kardiyol Dern Ars (2014) 0.77
A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case-control study. BMC Cardiovasc Disord (2012) 0.76
Step climbing capacity in patients with pulmonary hypertension. Clin Res Cardiol (2012) 0.76
Systemic sclerosis and early-onset pulmonary hypertension. Chest (2010) 0.75
Non-apical pacing: the right place to the right patient. Europace (2012) 0.75
Aqua lymphatic therapy for managing lower extremity lymphedema. J Am Acad Dermatol (2008) 0.75
Clinical relevance of endothelin B-mediated vasoconstriction in lambs with increased pulmonary blood flow. Circulation (2004) 0.75
From the echo bed to the pulmonary vascular bed: dobutamine testing in the noninvasive laboratory. Chest (2014) 0.75
Anatomical considerations for the development of a new transcatheter aortopulmonary shunt device in patients with severe pulmonary arterial hypertension. Pulm Circ (2013) 0.75
Bupropion for smoking cessation in patients hospitalized with cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials. Can J Cardiol (2013) 0.75